To the full analysis
Evonik Industries stock: growth
EVK.DEEvonik Industries reported $15.59B in revenue for fiscal 2025, down 7.2% on the prior year, up 2.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
0%
per year from 2006 to 2025, per share 0%
Earnings (Annual rate)
−7%
per year from 2006 to 2025, per share −6.9%
Free cash flow (Annual rate)
14%
per year from 2006 to 2025, per share 14%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 2.9% | 0.4% | 0.0% |
| Revenue per share | 2.9% | 0.4% | 0.0% |
| Earnings | −10.6% | −12.4% | −7.0% |
| Earnings per share | −11.7% | −12.4% | −6.9% |
| Free cash flow | −2.1% | −4.1% | 14.0% |
| Free cash flow per share | −2.1% | −4.1% | 14.0% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $15.65B | $1.16B | $64.27M |
| 2007 | $15.99B | $970.7M | $162.89M |
| 2008 | $17.59B | $315.81M | −$860.99M |
| 2009 | $14.49B | $265.94M | $1.42B |
| 2010 | $14.74B | $813.35M | $1.45B |
| 2011 | $16.11B | $1.12B | $469.83M |
| 2012 | $15.1B | $1.29B | $442.13M |
| 2013 | $14.27B | $2.28B | $5.54M |
| 2014 | $14.31B | $629.4M | −$32.13M |
| 2015 | $14.97B | $1.1B | $1.17B |
| 2016 | $14.11B | $935.24M | $897.56M |
| 2017 | $15.98B | $794.51M | $566.24M |
| 2018 | $16.65B | $1.03B | $744.64M |
| 2019 | $14.52B | $857.67M | $488.67M |
| 2020 | $13.52B | $515.27M | $854.35M |
| 2021 | $16.57B | $826.64M | $1.03B |
| 2022 | $20.49B | $598.37M | $869.86M |
| 2023 | $16.92B | −$515.27M | $887.59M |
| 2024 | $16.8B | $246M | $967.37M |
| 2025 | $15.59B | $293.65M | $770.13M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Sep 2026)
- Valuation signal Undervalued since 7 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.